HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mass spectrometry based identification of galectin-3 interacting proteins potentially involved in lung melanoma metastasis.

Abstract
Adhesive interactions between molecules on tumor cells and those on target organs play a key role in organ specific metastasis. Poly-N-acetyl-lactosamine (polyLacNAc) substituted N-oligosaccharides on melanoma cell surface glycoproteins promote lung specific metastasis via galectin-3 by facilitating their arrest and extravasation. This study reports the identification and characterization of galectin-3 interacting proteins using a combination of galectin-3 sepharose affinity and leucoagglutinating phytohemagglutinin (L-PHA) columns. A total of 83 proteins were identified as galectin-3 interacting glycoproteins, of which 35 were constituents of the L-PHA bound fraction, suggesting that these proteins carry polyLacNAc substituted β1,6 branched N-glycans. The identities of some of these proteins, like LAMP-1, LAMP-3, basigin, embigin, and α5 and β1 Integrin, have been confirmed by western blotting, and functional relevance with respect to metastatic properties has been established.
AuthorsManohar C Dange, Hemangi S Bhonsle, Rashmi K Godbole, Shyam K More, Sanjay M Bane, Mahesh J Kulkarni, Rajiv D Kalraiya
JournalMolecular bioSystems (Mol Biosyst) Vol. 13 Issue 11 Pg. 2303-2309 (Oct 24 2017) ISSN: 1742-2051 [Electronic] England
PMID28875213 (Publication Type: Journal Article)
Chemical References
  • Carrier Proteins
  • Galectin 3
Topics
  • Animals
  • Carrier Proteins (metabolism)
  • Chromatography, Affinity
  • Chromatography, Liquid
  • Galectin 3 (metabolism)
  • Lung Neoplasms (metabolism, secondary)
  • Mass Spectrometry (methods)
  • Melanoma (pathology)
  • Melanoma, Experimental
  • Mice
  • Protein Binding
  • Protein Interaction Mapping (methods)
  • Reproducibility of Results
  • Workflow

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: